AIA
ABCL icon

AssuredPartners Investment Advisors’s AbCellera Biologics ABCL Stock Holding History

AssuredPartners Investment Advisors’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.6K Buy
12,281
+2,262
+23% +$8.14K ﹤0.01% 401
2025
Q4 		$34.3K Buy
+10,019
New +$44.7K 0.01% 341
2025
Q2 		– Sell
-15,356
Closed -$34.2K – 240
2025
Q1 		$34.2K Buy
+15,356
New +$44K 0.01% 323

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AssuredPartners Investment Advisors's ABCL Position: Q1 2026 in Review

AssuredPartners Investment Advisors increased its AbCellera Biologics (ABCL) stake by 23% in Q1 2026, buying an estimated $8.14K and bringing the position to 12,281 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #401.

AssuredPartners Investment Advisors first reported a position in ABCL in Q1 2025 and has held it in 3 quarters since. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • AssuredPartners Investment Advisors held 12,281 shares of AbCellera Biologics worth $41.6K as of Q1 2026.
  • AssuredPartners Investment Advisors bought 2,262 AbCellera Biologics shares in Q1 2026, an estimated $8.14K.
  • AbCellera Biologics made up ﹤0.01% of AssuredPartners Investment Advisors's portfolio in Q1 2026, its #401 holding.
  • AssuredPartners Investment Advisors first reported a position in AbCellera Biologics in Q1 2025 and has held it in 3 quarters since.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.